Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

New pharmaceutical drugs in R&D pipelines in South Korea 2014, by therapeutic area

This statistic shows the number of new drugs in research and development (R&D) pipelines of major South Korean pharmaceutical companies in 2014, by therapeutic area. In that year there were 41 new anti-cancer drugs in the R&D pipelines of major Korean pharmaceutical companies.

New drugs in R&D pipelines of major pharmaceutical companies in South Korea in 2014, by therapeutic category

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2016

Region

South Korea

Survey time period

2014

Supplementary notes

Data is from a survey of over 41 leading pharmaceutical companies in South Korea.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.